Witness the major breakthroughs of microbiome, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.
See the Post Show report of our inaugural event here
Join us at Gen-Next Probiotics and Microbiome Congress, 2020 to network with biotech, pharma, academicians and investors to exchange views and observe the most ingenious research and technologies. Witness the amalgamation of study focused on pharmaceutical and medicinal approaches of probiotics and the nutraceutical and consumer approaches along with the role of microbiome in clinical applications and preventative medicine.
Chief Scientific Officer, Dakota Biotech
Director, Scientific Operations, , Clinical Microbiomics, Denmark
Lecturer, Imperial College London
Director, R&D Alliance Management, Ferring Pharmaceuticals
CEO, Phi Therapeutics
CCO , TenWise
Senior Process Engineer, Fluid Air, Australia
CEO, bitBiome, Japan
Digestive Health Therapeutic Platform Lead, , Metagenics, USA
Chief Scientific Officer , Viome
CEO, Symbiome, USA